LiqTech International, Inc. Receives Nasdaq Deficiency Notice for Minimum Bid Price Requirement
Key Highlights:
- LiqTech International, Inc. (Nasdaq: LIQT) has received a deficiency notice from The Nasdaq Stock Market.
- The notice states that the company’s common stock has failed to maintain a minimum closing bid price of \$1.00 for 30 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2).
- This notification does not result in immediate delisting; the company’s shares will continue to trade on the Nasdaq Capital Market under the symbol “LIQT”.
- LiqTech has been granted an initial 180-calendar day compliance period (until January 19, 2027) to regain compliance with the minimum bid price rule.
Details of the Nasdaq Deficiency Notice
On July 21, 2026, LiqTech International, Inc. (“the Company”) was formally notified by Nasdaq that its common stock failed to meet the \$1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The deficiency is based on the closing bid price of LiqTech’s common shares for the 30 consecutive business days prior to the notice.
Implications for Shareholders
- No Immediate Delisting: The Company’s shares continue to be listed and traded on Nasdaq, and there are no immediate changes to trading or shareholder rights.
- Compliance Period: LiqTech has 180 calendar days (until January 19, 2027) to regain compliance by having its closing bid price meet or exceed \$1.00 per share for at least ten consecutive business days.
- Potential Extension: If the Company does not regain compliance by the initial deadline, it may be eligible for a second 180-day period, provided it meets all other continued listing requirements (except the bid price) and notifies Nasdaq of its intent to cure the deficiency.
- Risk of Delisting: Failure to regain compliance during the allowed periods may result in Nasdaq initiating delisting proceedings. In such a case, the Company would have the right to appeal the decision to a Nasdaq Hearings Panel.
- Board Actions and Shareholder Impact: The Company is actively monitoring its share price and considering all options to regain compliance. Potential remedies may include reverse stock splits or other corporate actions, which could significantly affect the value and liquidity of shareholders’ holdings.
What Should Investors Watch?
- Any announcements regarding corporate actions (such as a reverse stock split), which are commonly used to regain compliance with minimum bid price rules.
- Progress updates from the Company regarding their compliance strategy and any potential communications from Nasdaq after January 19, 2027.
- Market reaction and trading volumes, as shares of companies facing delisting risks may experience increased volatility.
Leadership Confirmation
The report was signed by Fei Chen, Chief Executive Officer, on July 24, 2026, reaffirming the Company’s awareness of the matter and its intent to address the issue.
Investor Takeaway
This Nasdaq deficiency notice is a material development for LiqTech shareholders. While there are mechanisms in place for the Company to regain compliance, the risk of delisting is present if the minimum bid price is not restored. Shareholders should closely monitor the Company’s announcements and be aware that corporate actions to address the deficiency could materially impact their investment.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult with a qualified financial advisor before making any investment decisions. The information provided herein is based on the Company’s SEC filings and public disclosures as of the stated date and may be subject to change.
